2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Even as the Centers for Medicare & Medicaid Services (CMS) examines the implications of the ICD-10 delay there are some steps oncology and hematology practice managers can take now before the rollout gets into full swing.
Even as the Centers for Medicare & Medicaid Services (CMS) examines the implications of the ICD-10 delay—saying on its website that the agency will provide guidance to providers and stakeholders soon—there are some steps oncology and hematology practice managers can take now before the rollout gets into full swing.
First, CMS has provided resources for practices:
A blog posting by Kathleen LePar, vice president of strategic services at the consulting company, Beacon Partners, suggests some tips to take advantage of the delay. These include:
She writes that taking the time now to make sound operational changes to improve the revenue cycle process will make it easier to identify and mitigate risk as the transition approaches. With a projected 30% to 40% dip in cash expected following the transition, improving billing efficiency and productivity will allow practices to be reimbursed accurately.
Related Content: